Buy Outlook Therapeutics Inc Stock | OTLK Stock Price & Latest News | Public.com
OTLK

Outlook Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap
    View Outlook Therapeutics Inc (OTLK) stock trends here

    About OTLK

    Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification, development, manufacture, and commercialization of ONS-5010/LYTENAVA as the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal in...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.05
    -0.01
    -0.07
    -0.13
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.11

    Actual EPS
    Q4 2020

    -$0.12

    Stats

    Market Cap$376,34M
    Volume717,55k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.26
    1 Year Low$0.50
    Open$2.17
    High$2.36
    Low$2.14

    Buy any stock with any amount of money.

    Download the App
    Download the app